{"schema_version":"1","generated_at":"2026-10-30T09:40:11.374Z","data_as_of":null,"url":"https://www.findmykol.com/kol/steven-seung","json_url":"https://www.findmykol.com/kol/steven-seung/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"steven-seung","name":"Steven Seung","credential":"MD, PhD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Providence Portland Medical Center","institution_url":"https://www.findmykol.com/institution/providence-portland-medical-center","city":"Portland","state":"OR","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1396738431","openalex":"A5112535648"},"summary":"Steven Seung is an Oncology physician affiliated with Providence Portland Medical Center. OpenAlex indexes 37 publications with 1,063 citations (h-index 16); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":37,"cited_by_count":1063,"h_index":16,"latest_activity_year":2025,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01862900","title":"Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Providence Health & Services","source_url":"https://clinicaltrials.gov/study/NCT01862900","trial_url":"https://www.findmykol.com/trial/NCT01862900"},{"nct":"NCT01416831","title":"Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma.","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Providence Health & Services","source_url":"https://clinicaltrials.gov/study/NCT01416831","trial_url":"https://www.findmykol.com/trial/NCT01416831"},{"nct":"NCT00139633","title":"Selective Dose Escalation for Esophageal Cancer","phase":"PHASE2","status":"UNKNOWN","role":"Overall official","sponsor":"The Oregon Clinic","source_url":"https://clinicaltrials.gov/study/NCT00139633","trial_url":"https://www.findmykol.com/trial/NCT00139633"}],"source":"trials"},"payments":{"company_count":13,"program_years":{"first":2021,"last":null},"rows_total":21,"shown":3,"withheld":18,"rows":[{"payer":"Elekta, Inc.","program_year":2025,"amount_usd":1661.63,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1396738431"},{"payer":"Sumitomo Pharma America, Inc.","program_year":2025,"amount_usd":72.3,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1396738431"},{"payer":"Telix Pharmaceuticals","program_year":2025,"amount_usd":33.09,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1396738431"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1396738431","source":"payments"},"publications":{"total":38,"shown":5,"withheld":33,"matched_by":"OpenAlex author record","recent":[{"title":"Pathologic response to neoadjuvant sequenced, lymphatic-sparing SBRT plus pembrolizumab in HPV-negative head and neck squamous cell carcinoma.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.6084","status":"verified"},{"title":"Neoadjuvant SBRT followed by evorpacept and pembrolizumab in HPV-mediated head and neck squamous cell carcinoma: Investigation of pathologic response.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.e18101","status":"verified"},{"title":"MRI-Linac radiation therapy outcomes in patients with prostate, breast and other advanced malignancies.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.e13811","status":"verified"},{"title":"Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments","year":2022,"journal":"Clinical and Translational Radiation Oncology","source_url":"https://doi.org/10.1016/j.ctro.2022.11.013","status":"verified"},{"title":"Patterns of Utilization and Clinical Adoption of 0.35 MR-Guided Radiation Therapy in the United States — Understanding the Transition to Adaptive, Ultra-Hypofractionated Treatments","year":2021,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2021.07.1400","status":"verified"}],"source":"works"},"contact":{"address_1":"4805 NE GLISAN ST","address_2":"GARDEN LEVEL","city":"Portland","state":"OR","zip":"972132933","phone":"503-215-6029","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1396738431","source":"identity"},"similar":[{"name":"John Heffner","slug":"john-heffner","institution":"Providence Portland Medical Center","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/john-heffner","json_url":"https://www.findmykol.com/kol/john-heffner/profile.json"},{"name":"John Godwin","slug":"john-godwin","institution":"Providence Portland Medical Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/john-godwin","json_url":"https://www.findmykol.com/kol/john-godwin/profile.json"},{"name":"Alison Conlin","slug":"alison-conlin","institution":"Providence Portland Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/alison-conlin","json_url":"https://www.findmykol.com/kol/alison-conlin/profile.json"},{"name":"Rom Leidner","slug":"rom-leidner","institution":"Providence Portland Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/rom-leidner","json_url":"https://www.findmykol.com/kol/rom-leidner/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":18,"publications":33}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-12-05","provider_certified":"2023-12-05","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}